Skip to main content
Op-Ed

Ebola Should Have Never Left Africa

The spread of Ebola from Africa to Europe and the United States should never have occurred.

Although the disease has been known in Africa since 1976, the various outbreaks have been controlled at relatively low economic costs for the global community, although high costs locally.

Ebola is a deadly disease with a high mortality rate but, with appropriate intervention, the high death rate, combined with the nature of transmission through bodily fluids, makes it relatively easy to control within proper functioning health systems.

This is in stark contrast with other historical pandemics, particularly influenza strains such as H5N1. The scale of the outbreak of Ebola in Guinea, Sierra Leone and Liberia can largely be attributed to the lack of capacity in the public health system to deal with the disease.

By August 8, the World Health Organisation declared the epidemic to be a public health emergency. It is now spreading to other countries, although it is unlikely to be a major crisis outside Africa because response systems are in place in many countries. What is so problematic is that a small amount of intervention initially by the world community could have avoided what is likely to be a very high-cost investment in protecting the global community.

There have been a number of studies of the economic cost of pandemics and they all show that the cost of taking action after a disease has become a pandemic and waiting for national intervention to occur at the border is orders of magnitude larger than the cost of taking action at the source of the disease to prevent the pandemic from emerging. In studies of the 2002 SARS outbreak for the US Institute of Medicine, Jong-Wha Lee and I found that SARS cost the world economy around $US40 billion ($45 billion – the official WHO estimate).

In 2006, Alexandra Sidorenko and I undertook a major study on the global macro-economic consequences of an influenza pandemic for the Australian National University and the Lowy Institute, mapping the epidemiological experience of the influenza pandemics of the 1968-69 Hong Kong flu, the 1957 Asian flu and the 1918-19 Spanish flu, on to the current global economy. We found that in today’s integrated world, similar pandemics may kill between 1.4 million and 144 million people. The economic cost could run between $US340 billion for the Hong Kong flu and $US4.4 trillion for the worst scenario of the Spanish flu. Of course these estimates are highly uncertain, but the costs are orders of magnitude greater than the funding from the international community currently going into the prevention of pandemics. Ebola is unlikely to be in the same league as these historical influenza pandemics because of its particular epidemiological characteristics, but there are at least two important lessons to be learnt from the most recent outbreak.

Long-term investments needed

The first is that there is a wide range of zoonotic diseases that could potentially become human pandemics. Most of these events will emerge in overcrowded, poor communities where animals and humans mix extensively and public health systems are fragile. To minimise the risk of a major pandemic in future years, serious long-term investments need to be made to significantly improve the healthcare systems in the world’s poorest countries.

The second lesson is that extensive investment is needed to enable early intervention in countries where outbreaks do occur. To have response plans tuned to protecting borders is politically attractive but far more costly than focusing on the source of the disease. A failure to co-ordinate global health policy responses will be far more socially and economically devastating than the lack of co-ordination of macro-economic policies that currently damage the global economy.

There is a long history of experience and a large amount of evidence of what needs to be done to deal with pandemics. There is extensive evidence that the benefits of intervention before a disease outbreak becomes a pandemic are far greater than the costs of such intervention.

The failure of response to the Ebola outbreak of 2014 is a timely reminder of what needs to be done in the global community to better co-ordinate global health policy.

Author

Get daily updates from Brookings